Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
DBV Technologies S.A. - Spons-ADR
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.
Find out what a historical investment in DBV Technologies S.A. - Spons-ADR would be worth today using our DBVT stock calculator.
Market Capitalisation
$1.04B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
108.15K
High today
$18.90
Low today
$18.37
Open price
$18.61
52-week high
$26.19
52-week low
$7.53
Ready to start your investing journey with Stake?
Open an accountHow do I buy DBVT shares in Australia?
Buying DBVT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in DBV Technologies S.A. - Spons-ADR in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in DBVT
What is the ticker symbol of DBV Technologies S.A. - Spons-ADR ?
The ticker symbol for DBV Technologies S.A. - Spons-ADR is DBVT.
How much is one share of DBVT?
One share of DBVT is valued at $18.48 as of 20 May 2026.
What is the market capitalisation of DBV Technologies S.A. - Spons-ADR DBVT?
As of 20 May 2026 DBV Technologies S.A. - Spons-ADR has a market cap of $1.04B.
What is the 52-week high for DBV Technologies S.A. - Spons-ADR stock?
The DBV Technologies S.A. - Spons-ADR 52-week high stock price is $26.19.
What is the 52-week low for DBV Technologies S.A. - Spons-ADR stock?
The DBV Technologies S.A. - Spons-ADR 52-week low stock price is $7.53.
Can I buy DBVT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy DBVT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in DBVT on Stake
- Buy DBVT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of DBVT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
DBVT related stocks